BRCA1 and breast carcinoma: For this purpose, we used as study models the breast cancer-derived cell line HCC1395, which carries the pathogenic nonsense variant R1751X in homozygosis, and a set of HeLa cells stably expressing BRCA1 C-terminal constructs carrying selected nonsense variants.